eMedicine Specialties > Psychiatry > Psychosomatic

Munchausen Syndrome: Treatment & Medication

Author: James C Hamilton, PhD, Associate Professor, Coordinator of Clinical Health Psychology, Department of Psychology, Clinical Affiliate Associate Professor of Internal Medicine, University of Alabama
Coauthor(s): Marc D Feldman, MD, Clinical Professor of Psychiatry, Department of Psychiatry and Behavioral Medicine, and Adjunct Professor, Department of Psychology, University of Alabama, Tuscaloosa, AL
Contributor Information and Disclosures

Updated: Sep 16, 2009

Treatment

Medical Care

In essence, the medical care of persons thought to have Munchausen syndrome should proceed in the same manner as the medical care of any other patient, despite the dramatic or compelling nature of the patient's problem or his or her demands for additional invasive and noninvasive intervention. As noted in the previous section, remember that these patients attempt to fool the treating physician into conducting more tests and trying more treatments than are necessary. When they succeed in doing so, it is often because of a failure to include factitious disorder and Munchausen syndrome in the differential. On the other hand, medical professionals are taught that the most important clue to a patient's diagnosis is the information they provide, and doctors should not abandon their belief in and advocacy for patients unless risk factors are present or suggestive signs arise.

Surgical Care

For patients with known or suspected Munchausen syndrome, use great caution in deciding to proceed with surgical treatment, particularly when the surgery involves an irreversible result such as amputation, radical mastectomy, or organ removal. Do not assume that a patient with factitious disorder would not play out the ruse to the point of acquiring a permanent disability or disfigurement—the case literature is replete with reports of patients who have done so. Remember that performing surgery on a patient gives him or her a legitimate sick role status, at least during the recovery period, perhaps longer in cases in which the surgery appears to result in complications or otherwise creates unexpected and unwanted physical consequences.

Consultations

The general practitioner who encounters a patient with Munchausen syndrome often makes specialty referrals in response to the puzzling or intractable symptoms that the patient presents. The specialist consultations should be carefully coordinated by the primary care provider. In some cases involving patients with Munchausen syndrome who have filed malpractice suits, the staggering number of concurrent treating and prescribing physicians can incriminate the doctor if he or she failed to ask about outside care. Referrals should be kept to a minimum; the primary care physician should serve as much more than a conduit for consultations. Referral issues, including any indication of Munchausen syndrome, should be clearly spelled out.

The patient's refusal to sign release of information forms should be thoroughly questioned and is a warning sign. The primary care physician should firmly resist attempts by the patient to exert inappropriate control over the consultation (eg, choosing the specialist, insisting on personally communicating the results to the primary care provider). Termination from the doctor's practice may have to be considered, although this measure does nothing to attenuate the root problem.

When the physician strongly believes that the patient is feigning illness or injury, it is natural to request a psychiatry consultation. Before doing so, the primary care physician should consider several issues.

First, no definitive affirmative psychiatric criteria exist for the diagnosis of factitious disorder. Second, the patient is unlikely to cooperate with a psychiatry consultation, so no new information will be elicited. Not only will the patient usually not agree to the consultation, he or she may leave the physician's care, angered by the implication that the physician believes that the patient is faking. Similarly, psychological testing is nondiagnostic, though it can be telling if a patient feigning mental illness receives discrepant scores on objective, well-validated tests. For these reasons, a typical psychiatric or psychological evaluation is not often effective in these cases. Additionally, as a group, psychiatrists and psychologists have no greater ability than average lay persons in discerning lying during interviews.

Still, it may be helpful for the physician to discuss the case with an experienced psychiatric consultant who can advise the physician, and sometimes the entire treatment team, on how to proceed with the evaluation and management of a patient with Munchausen syndrome.

After a diagnosis of factitious disorder has been established, it may prove more useful to conduct consultations with mental health professionals who practice behavioral medicine, reserving psychopharmacologic management for patients with clearcut mental disorders such as major depression. These professionals might include psychiatrists, psychologists, or social workers. Consultations may be acceptable to the patient if they are portrayed as aimed at helping the patient to cope with their medical problems and to understand more about the influence of the brain on the body. This approach can succeed because it places the patient in contact with mental health professionals in a way that does not challenge the patient's assertion that the problem is an authentic medical one. Ongoing psychotherapy5 can provide the patient with a time and place in which they are guaranteed the exclusive attention of a health care professional without resorting to "disease forgery."

Activity

If the patient is hospitalized, it may be important to limit his or her activities to the unit and to minimize the time he or she spends alone. Freedom to come and go (as on some psychiatric units) or infrequent checks offer increased opportunities for patients with Munchausen syndrome to self-induce renewed bouts of illness. Room searches (eg, for syringes or hidden medications) may be necessary, and permission to do so is commonly part of the consent forms patients sign before admission.

Medication

No drug treatment trials specifically relate to pharmacological interventions for chronic factitious disorder.

Patients with comorbid depression or anxiety may benefit from pharmacotherapy with nonabusable medications such as serotonin reuptake inhibitors, though these medicines are very unlikely to reverse the patient's illness behavior problems.

Caregivers should routinely copy each other on every progress note and prescription written, with ongoing care contingent on the patient's signing the suitable consent forms. If abusable medications must be used (eg, because of a lack of response to nonabusable agents), firm written contracts should be signed by doctor, patient, and at least one witness. Examples are usually available from state medical licensure boards or pain-management colleagues. Contract provisions might include statements that no replacement pills will be provided if the patient claims to have lost their medication in some way and that the patient will submit to random urine or serum blood screens to exclude use of street drugs and to detect drug levels too high to be explained by use as the doctor instructed.

More on Munchausen Syndrome

Overview: Munchausen Syndrome
Differential Diagnoses & Workup: Munchausen Syndrome
Treatment & Medication: Munchausen Syndrome
Follow-up: Munchausen Syndrome
Multimedia: Munchausen Syndrome
References
Further Reading

References

  1. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, 4th Edition, Text Revision. Washington, DC, American Psychiatric Association. 2000.

  2. Mountz JM, Parker PE, Liu HG, Bentley TW, Lill DW, Deutsch G. Tc-99m HMPAO brain SPECT scanning in Munchausen syndrome. J Psychiatry Neurosci. Jan 1996;21(1):49-52. [Medline].

  3. Sutherland AJ, Rodin GM. Factitious disorders in a general hospital setting: clinical features and a review of the literature. Psychosomatics. Fall 1990;31(4):392-9. [Medline].

  4. Fliege H, Grimm A, Eckhardt-Henn A, Gieler U, Martin K, Klapp BF. Frequency of ICD-10 factitious disorder: survey of senior hospital consultants and physicians in private practice. Psychosomatics. Jan-Feb 2007;48(1):60-4. [Medline].

  5. Plassmann R. Inpatient and outpatient long-term psychotherapy of patients suffering from factitious disorders. Psychother Psychosom. 1994;62(1-2):96-107. [Medline].

  6. Aduan RP, Fauci AS, Dale DC. Factitious fever and self-induced infection: a report of 32 cases and review of the literature. Ann Intern Med. Feb 1979;90(2):230-42. [Medline].

  7. ASHER R. Munchausen's syndrome. Lancet. Feb 10 1951;1(6650):339-41. [Medline].

  8. Babe KS Jr, Peterson AM, Loosen PT. The pathogenesis of Munchausen syndrome. A review and case report. Gen Hosp Psychiatry. Jul 1992;14(4):273-6. [Medline].

  9. Baile WF Jr, Kuehn CV, Straker D. Factitious cancer. Psychosomatics. Winter 1992;33(1):100-5. [Medline].

  10. Eastwood S, Bisson JI. Management of factitious disorders: a systematic review. Psychother Psychosom. 2008;77(4):209-18. [Medline].

  11. Ehlers W, Plassmann R. Diagnosis of narcissistic self-esteem regulation in patients with factitious illness (Munchausen syndrome). Psychother Psychosom. 1994;62(1-2):69-77. [Medline].

  12. Feldman MD. Playing Sick?: Untangling the Web of Munchausen Syndrome, Munchausen by Proxy, Malingering, and Factitious Disorder. New York, Routledge. 2004.

  13. Feldman MD. Web alert. Curr Psychiatry Rep. Oct 2000;2(5):367-8. [Medline].

  14. Feldman MD, Eisendrath SJ. The Spectrum of Factitious Disorders. Washington, DC: American Psychiatric Press; 1996.

  15. Feldman MD, Hamilton JC. "Chest pain" in patients with factitious disorder including Munchausen syndrome. In: Hurst JW, Morris DC, eds. Chest Pain. Armonk, NY: Futura; 2001.

  16. Feldman MD, Hamilton JC. Serial factitious disorder and Munchausen by proxy in pregnancy. Int J Clin Pract. Dec 2006;60(12):1675-8. [Medline].

  17. Feldman MD, Miner ID. Factitious Usher syndrome: a new type of factitious disorder. Medscape Journal of Medicine [serial online]. June 30, 2008;10:153. Available from: http://www.medscape.com/viewarticle/575253. Accessed March 22, 2009. Available at www.medscape.com/viewarticle/575253.

  18. Folks DG. Munchausen's syndrome and other factitious disorders. Neurol Clin. May 1995;13(2):267-81. [Medline].

  19. Folks DG, Feldman MD, Ford CV. Somatoform disorders, factitious disorders, and malingering. In: Stoudemire A, Fogel BS, Greenberg DB, eds. Psychiatric Care of the Medical Patient. 2nd ed. New York: Oxford University Press; 2000:459-475.

  20. Gattaz WF, Dressing H, Hewer W. Munchhausen syndrome: psychopathology and management. Psychopathology. 1990;23(1):33-9. [Medline].

  21. Gavin H. On Feigned and Factitious Diseases. London, England: John Churchill; 1843.

  22. Hamilton JC, Feldman MD. Factitious disorders. In: Phillips KA, ed. Somatoform and Factitious Disorders. Washington, DC: American Psychiatric Publishing; 2001:129-166.

  23. Hamilton JC, Feldman MD, Janata JW. The A, B, C's of factitious disorder: a response to Turner. Medscape J Med. 2009;11(1):27. [Medline][Full Text].

  24. Krahn LE, Bostwick JM, Stonnington CM. Looking toward DSM-V: should factitious disorder become a subtype of somatoform disorder?. Psychosomatics. Jul-Aug 2008;49(4):277-82. [Medline].

  25. Krahn LE, Li H, O'Connor MK. Patients who strive to be ill: factitious disorder with physical symptoms. Am J Psychiatry. Jun 2003;160(6):1163-8. [Medline].

  26. Turner MA. Factitious disorders: reformulating the DSM-IV criteria. Psychosomatics. Jan-Feb 2006;47(1):23-32. [Medline].

Further Reading

Feldman MD. Playing Sick? Untangling the Web of Munchausen Syndrome, Munchausen by Proxy, Malingering, and Factitious Disorder. New York, Routledge, 2004

Selected Web sites

How Munchausen Syndrome Works

The Merck Manual entry on Munchausen syndrome

Cybersickness

Dr. Feldman's Munchausen Syndrome, Factitious Disorder, Malingering, and Munchausen by Proxy Site

Keywords

factitious disorder, FD, hospital hobo, pseudosickness, pathomimicry, disease forgery, scalpellophilia, mania operativa activa, surgery mania, artefactual patients, doctor addicts, hospital hoppers, hospital addicts, professional patients, false patients, operation addicts, pseudologues, peregrinating problem patients, pseudologia fantastica, hypochondriasis, hypochondriac, malingering, goldbricking, black hole patients, heart-sinkers

Contributor Information and Disclosures

Author

James C Hamilton, PhD, Associate Professor, Coordinator of Clinical Health Psychology, Department of Psychology, Clinical Affiliate Associate Professor of Internal Medicine, University of Alabama
James C Hamilton, PhD is a member of the following medical societies: American Psychological Society, American Psychosomatic Society, International Society for Self and Identity, Phi Beta Kappa, and Society for Personality and Social Psychology
Disclosure: Nothing to disclose.

Coauthor(s)

Marc D Feldman, MD, Clinical Professor of Psychiatry, Department of Psychiatry and Behavioral Medicine, and Adjunct Professor, Department of Psychology, University of Alabama, Tuscaloosa, AL
Marc D Feldman, MD is a member of the following medical societies: Academy of Psychosomatic Medicine and American Psychiatric Association
Disclosure: Nothing to disclose.

Medical Editor

Ronald C Albucher, MD, Chief Medical Officer, Westside Community Services; Consulting Staff, California Pacific Medical Center
Ronald C Albucher, MD is a member of the following medical societies: American Psychiatric Association
Disclosure: Nothing to disclose.

Pharmacy Editor

Francisco Talavera, PharmD, PhD, Senior Pharmacy Editor, eMedicine
Disclosure: eMedicine Salary Employment

Managing Editor

Eduardo Dunayevich, MD, Adjunct Assistant Professor, Department of Psychiatry, University of Cincinnati; Clinical Research Physician, Neuroscience, Lilly Research Laboratories
Eduardo Dunayevich, MD is a member of the following medical societies: American Psychiatric Association
Disclosure: Nothing to disclose.

CME Editor

Harold H Harsch, MD, Program Director of Geropsychiatry, Department of Geriatrics/Gerontology, Associate Professor, Department of Psychiatry and Department of Medicine, Froedtert Hospital, Medical College of Wisconsin
Harold H Harsch, MD is a member of the following medical societies: American Psychiatric Association
Disclosure: lilly Honoraria Speaking and teaching; Forest Labs Honoraria Speaking and teaching; AstraZeneca Honoraria Speaking and teaching; Pfizer Grant/research funds Speaking and teaching; Northstar Grant/research funds Research; Novartis Grant/research funds research; Pfizer  Speaking and teaching; Sanofi-avetis Grant/research funds research; Otsuke Grant/research funds reseach; GlaxoSmithKline Grant/research funds research

Chief Editor

Stephen Soreff, MD, President of Education Initiatives, Nottingham, NH; Faculty, Metropolitan College of Boston University, Boston, MA
Stephen Soreff, MD is a member of the following medical societies: American College of Mental Health Administration and American Psychosomatic Society
Disclosure: Nothing to disclose.

 
 
HONcode

We subscribe to the
HONcode principles of the
Health On the Net Foundation

All material on this website is protected by copyright, Copyright© 1994- by Medscape.
This website also contains material copyrighted by 3rd parties.

DISCLAIMER: The content of this Website is not influenced by sponsors. The site is designed primarily for use by qualified physicians and other medical professionals. The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The information provided here is for educational and informational purposes only. In no way should it be considered as offering medical advice. Please check with a physician if you suspect you are ill.